MOREPEN LABORATORIES LIMITED

Press Releases Morepen Laboratories Limited NSE India S.E.

Equities

MOREPENLAB

INE083A01026

Market Closed - NSE India S.E. Other stock markets 07:43:49 2024-05-07 am EDT			5-day change	1st Jan Change
46.6 ^INR	-2.92%		-7.81%	-4.02%

Mar. 30	Morepen Laboratories Limited Announces Resignation of Lalit Kumar Baregama, Chief Growth Officer	CI
Mar. 01	Morepen Laboratories Limited Announces the Promotion of Amita Sharma to Chief Operating Officer -API	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morepen Laboratories : Change in the date of appointment of Mr. Nishant Jayesh Doshi, V P - Corp. Fin. & Investor Relations ('SMP') Change in Senior Management Personnel - Mr. Rajesh Kumar Singh	May. 02	PU
Morepen Laboratories : Dr. Morepen Partners with OptiBiotix to Deliver Safe, ScienceBacked Weight Management Solution to India	Mar. 19	PU
Morepen Laboratories : Investors presentation - Q1' FY 2023-24	23-08-08	PU
Morepen Laboratories : Transcript of EGM dated March 05, 2022 Audited Financial results for the quarter and financial year ended March 31, 2022 Unaudited financial results for the quarter and nine months ended December 31, 2021 Unaudited Financial results for the quarter and half year ended September 30, 2021 Unaudited Financial results for the quarter ended June 30, 2021	22-09-08	PU
Morepen Laboratories : Investor Presentation Q1' FY 2022-23	22-07-29	PU
Morepen Laboratories : Unaudited Financial results for the quarter ended June 30, 2022	22-07-29	PU
Morepen Laboratories : Conversion	22-03-30	PU
Morepen Laboratories : Extra Ordinary Meeting	22-02-26	PU
Morepen Laboratories : Investor Presentation Q3' FY 2021-22	22-02-08	PU
Morepen Laboratories : Labs Q3 Revenue up by 29% with 14% jump in Profit before Tax (PBT), 43% increase in API Export	22-02-08	PU
Morepen Laboratories : gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4’FY22	21-12-03	PU
Morepen records 70 percent increase in Profit before tax in Q2 Consolidated Revenue grows by 17%	21-11-11	PU
Investor Presentation Q2'FY2021-22	21-11-11	PU
Morepen Laboratories : Press Release 29 September 2021	21-09-28	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW